SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001144204-17-023657
Filing Date
2017-05-01
Accepted
2017-05-01 16:31:46
Documents
6
Period of Report
2017-06-27
Effectiveness Date
2017-05-01

Document Format Files

Seq Description Document Type Size
1 DEF 14A v465333_def14a.htm DEF 14A 1038616
2 GRAPHIC line.gif GRAPHIC 43
3 GRAPHIC logo_intercept-new.jpg GRAPHIC 34913
4 GRAPHIC sig_mpruzanski.jpg GRAPHIC 14498
5 GRAPHIC sig_bryan-yoon.jpg GRAPHIC 28030
6 GRAPHIC spacer.gif GRAPHIC 43
  Complete submission text file 0001144204-17-023657.txt   1146925
Mailing Address 450 W. 15TH STREET SUITE 505 New York NY 10011
Business Address 450 W. 15TH STREET SUITE 505 NEW YORK NY 10011 646-747-1000
INTERCEPT PHARMACEUTICALS INC (Filer) CIK: 0001270073 (see all company filings)

IRS No.: 223868459 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-35668 | Film No.: 17801196
SIC: 2834 Pharmaceutical Preparations